Journal
JOURNAL OF NEUROCHEMISTRY
Volume 126, Issue 3, Pages 312-317Publisher
WILEY
DOI: 10.1111/jnc.12288
Keywords
Alzheimer's disease; lactadherin; neuroinflammation; phosphatidylserine; SED1
Categories
Funding
- Wellcome Trust [RG50995]
Ask authors/readers for more resources
Nanomolar -amyloid peptide (A) can induce neuronal loss in culture by activating microglia to phagocytose neurons. We report here that this neuronal loss is mediated by the bridging protein lactadherin/milk-fat globule epidermal growth factor-like factor 8 (MFG-E8), which is released by A-activated microglia, binds to co-cultured neurons and opsonizes neurons for phagocytosis by microglia. A stimulated microglial phagocytosis, but did not opsonize neurons for phagocytosis. A (250nM) induced delayed neuronal loss in mixed glial-neuronal mouse cultures that required microglia and occurred without increasing neuronal apoptosis or necrosis. This neuronal death/loss was prevented by antibodies to MFG-E8 and was absent in cultures from Mfge8 knockout mice (leaving viable neurons), but was reconstituted by addition of recombinant MFG-E8. Thus, nanomolar A caused neuronal death by inducing microglia to phagocytose otherwise viable neurons via MFG-E8. The direct neurotoxicity of micromolar A was not affected by MFG-E8. The essential role of MFG-E8 in A-induced phagoptosis, suggests this bridging protein as a potential therapeutic target to prevent neuronal loss in Alzheimer's disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available